On November 9, the United States Food and Drug Administration issued an emergency use authorization (EUA) to bamlanivimab for the treatment of mild-to-moderate COVID-19. The monoclonal antibody therapy is authorized for COVID-19 patients…

The American pharmaceutical company Pfizer reported that its COVID-19 vaccine is highly effective in preventing infection with the novel coronavirus in preliminary studies. In light of rising case numbers across the United States, this is…

Sunstar Americas, Inc. (SAI) is voluntarily recalling Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 6/30/22 – 9/30/22 (see specific lots below) to the consumer level.  This product may be…

A mutated version of the coronavirus has infected the farmed mink population in Denmark, the largest supplier of mink fur in the world. Thus far, the mutation has impacted more than 200 mink farms and over 200 Danes have been infected with…

Columbia University researchers have developed a nasal spray designed to prevent infection with the novel coronavirus, and an initial study conducted on ferrets demonstrates efficacy. While the study was small and has not undergone peer…

The United States Food and Drug Administration (FDA) asked two companies to stop selling products due to false claims made about their ability to prevent and/or treat the illness associated with the novel coronavirus. The requests were…

For the first time since the inception of the global pandemic, the United States reported more than 100,000 new cases of COVID-19 in one day on November 3. Maine, Minnesota, Indiana, Nebraska, and Colorado reported record-high case numbers,…

Individuals living in areas with high levels of air pollution—such as Los Angeles, Phoenix, Salt Lake City, and Las Vegas—may be at greater risk of death due to COVID-19, according to new research published in Science Advances. Researchers…

This information is from the article What Are the Contraindications to Chlorhexidine Use by Ann Eshenaur Spolarich, RDH, PhD, FSCDH. To read the article, click here.

Abdominal pain, nausea, vomiting, diarrhea, and appetite loss are gastrointestinal symptoms reported among those with COVID-19 illness. According to a University of Alberta study, these symptoms may be the only ones noted in approximately…